Anahita Bassir Nia, MD; Jeremy Weleff, DO; Nia Fogelman, PhD; and Rajita Sinha, PhD, are co-authors of a paper in Journal of Psychiatric Research that found people who use cannabis regularly have higher rates of childhood trauma and lifetime trauma.
- March 06, 2023Source: MedPage Today
Harlan Krumholz, MD, discusses his new framework for improving hypertension outcomes.
- March 06, 2023
Enhancing Treatment for Persistent Hypertension: Unleashing the Power of Actionable Taxonomy from EHR Data for Precision Medicine
In the United States, a significant number of patients continue to struggle with persistent hypertension.
- March 06, 2023
YCCI Interim Director, Dr. David Coleman, recipient of the 2023 Larry Zaroff Man of Good Conscious Award
New Interim Director of YCCI David Coleman, MD, Research Professor of Medicine, Emeritus Professor, Yale School of Medicine, is a recipient of the 2023 Larry Zaroff Man of Good Conscious Award from the American Medical Women’s Association. The Association presents this award annually to a man who has been a champion and supporter of women in medicine.
- March 03, 2023
Researchers found persons living with dementia and multiple chronic conditions enjoyed the health priorities identification process and appreciated having their care partner present and actively listening.
- March 02, 2023
New Data Reported From Trials of Drug Developed at Yale Pathology to Treat Rare, Often Fatal Neonatal Disorder
Clinical trial data from an enzyme-therapy drug developed at Yale Pathology to treat a rare and often fatal neonatal calcification disorder were recently reported. The drug, INZ-701, was designed and validated in the laboratory of Demetrios Braddock, MD, PhD, Associate Professor of Pathology at Yale School of Medicine.
- February 28, 2023
Jennifer Miller, PhD, associate professor of medicine (general medicine), specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation.
- February 28, 2023Source: The Washington Post
The popular artificial sweetener erythritol, which is used as a sugar substitute in many low-calorie, low-carb and keto products, has been linked to heightened risk of heart attack, stroke and death, according to a study published in Nature Medicine.
- February 23, 2023
We are writing to announce a request for applications for supplemental research support from early-career physician-scientists and scientists who face significant caregiving demands. The goal of the program is to retain such scientists in the research enterprise. Funding is provided by the Fund to Retain Clinical Scientists at the Yale School of Medicine (FRCS), funded by the Doris Duke Charitable Foundation, and the Yale School of Medicine. Our process will consider the degree of demonstrated caregiving burden and prioritize applicants with limited access to other resources, such as institutional support packages. Funds can be used to “buy out” clinical obligations or to hire additional research staff to optimize research activities.
- February 21, 2023
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.